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Background: Chromogranin A (CgA) in plasma (P-CgA), a neuroendocrine marker of sympathetic stress,
has been shown to predict mortality in medical intensive care. We hypothesized that the magnitude of
CgA release would reﬂect stress load, and thereby injury severity in burn intensive care patients.
Methods: Fifty-one consecutive patients with a burn area exceeding 10% were included. P-CgA was mea-
sured twice daily for seven days after injury. The point value at 24 h, the mean and maximum values and
the AUC at days 1–7, were tested as possible predictors. Injury severity in the form of organ dysfunction
was measured as SOFA score at day 7.
Results: P-CgA could be classiﬁed into two types with respect to variability over time. Patients with high
variability had more deep injuries and were older than those with low variability. All measures of CgA
correlated with SOFA score at day 7, but not with total burn size. Univariate regressions showed that
age, burn size and three of four measures of P-CgA predicted organ dysfunction. Multiple regressions
showed that age, burn size, and either P-CgA at 24 h, the mean value up to day 7, or the maximum value
up to day 7, were independent predictors for organ dysfunction. Signiﬁcant organ dysfunction was best
predicted by age, burn area and the CgA point value at 24 h with an AUC value of 0.91 in a ROC-analysis.
Conclusions: The extent of neuroendocrine activation assessed as P-CgA after a major burn injury is inde-
pendently related to organ dysfunction.
 2012 Elsevier Ltd. Open access under CC BY-NC-ND license.1. Introduction
Patients with large burn injuries are exposed to a severe acute
stress response, and those with injuries with a TBSA% (total body
surface area percent) burned greater than 10–15% usually require
intensive care due to the impact of the injury on vital organ func-
tion. There are large differences in preburn morbidity, the type and
severity of injury, the physiologic stress response to the trauma,
and the number and severity of complications during care (ABA,
2011). These factors make comparisons between different patients
difﬁcult, as well as assessments of the prognosis for individual pa-
tients. They also point to the importance of an accurate system for
objectively describing severity, risk and prognosis for burn patients
in intensive care.ects number 2002-6214 and
and Uppsala County Council.
Surgical Sciences, Uppsala
psala, Sweden. Tel.: +46 706
din).
Y-NC-ND license.Traditionally, TBSA burned or variants thereof such as the Baux
Score (Age + TBSA burned), the BI (Burn Index = TBSA full thickness
burn + ½ TBSA partial thickness burn) (Nakae andWada, 2002), the
PBI (Prognostic Burn Index = BI + age) (Nakae and Wada, 2002;
Morita et al., 2010), and age + TBSA burned + inhalation injury
(Smith et al., 1994) have been used for describing the severity of
injury and in assessing prognosis in terms of mortality. These are
convenient but imprecise measures, especially in elderly burn pa-
tients and in patients with severe underlying illness (Nakae and
Wada, 2002; Lionelli et al., 2005; Tanaka et al., 2007). Mortality
predictions using additional variables marginally improve accu-
racy at the expense of simplicity (Galeiras et al., 2009). These re-
sults suggest that individual factors other than age and burn size
affect mortality.
During the past 25 years, ICU (Intensive Care Unit) scoring mod-
els have undergone signiﬁcant development, validation and reﬁne-
ment. They either predict mortality based on physiological
variables collected in the ﬁrst 24 h of ICU stay, or on the degree
of organ dysfunction over time as organ systems show signs of
worsening function or failure (Vincent et al., 1998). Many of the
clinical variables measured as part of these ICU scoring models
reﬂect the degree of sympathetic response to a life-threatening
Table 1
Characteristics of the individuals included in the study.a
Included 52
Did not want to participate 1
Sufﬁcient data for SOFA-scoring not available 12
Study population 39
Female gender 12/39
Age (years) 45.0 (range 20–82)
TBSA (percent) 30.5 (range 10–95.5)
TBSA full thickness (percent) 13 (range 0–94.5)
Length of stay (days) 20.5 (range 4–183)
Died during stay 4/39
Cause of injury
Fire (including explosion and contact) 32
Scald 3
Electrical 2
Chemical 2
Carbon monoxide intoxication 4
a Data is given as integers or median and range.
208 A.E. Lindahl et al. / Neuropeptides 47 (2013) 207–212illness and/or the trauma elicited by different care related mea-
sures (Dunser and Hasibeder, 2009). We therefore commenced this
study by hypothesizing that a simple measurement reﬂecting sym-
pathetic overactivity would be related to clinical severity in burn
patients during the intensive care phase.
One recognized biomarker of stress and sympathetic overactiv-
ity is the concentration of chromogranin A (CgA) in plasma (P-CgA)
(Cryer et al., 1991). CgA is a glycoprotein of 48–52 kDa, which is co-
secreted with epinephrine and norepinephrine by chromafﬁn cells
from the adrenal medulla and also together with hormones from
the neuroendocrine system (Taupenot et al., 2003). It can be de-
graded to a number of split products with tissue speciﬁc activity
(Taupenot et al., 2003), among them the antiadrenergic vasosta-
tins, and catestatin, which inﬂuences the release of catechola-
mines, has a negative inotropic effect and decreases vascular
contractility (Mazza et al., 2010). Furthermore, it was recently
shown that a point measure of P-CgA in medical patients on admis-
sion to the ICU was a strong and independent predictor of mortal-
ity (Zhang et al., 2008, 2009; Galeiras et al., 2009; Røsjø et al.,
2010).
The primary aim of this paper was based on the hypothesis that
there are considerable interindividual differences in neuroendo-
crine activation and stress load after injury, and that these differ-
ences contribute to the risk of developing organ dysfunction
during the acute intensive care period. We therefore ﬁrst assessed
the degree to which the stress of a severe injury in the form of a
large burn is reﬂected in measurable increases in P-CgA, and sub-
sequently described how different measures of P-CgA in the acute
phase after a major burn injury are related to organ dysfunction
one week after injury measured as the Sequential Organ Failure
Assessment (SOFA) score, which is a good measure of organ dys-
function (Lorente et al., 2009) and predictor of mortality (Nguyen
and Nguyen, 2009) in burn patients.2. Materials and methods
2.1. Patients
Patients were recruited consecutively between October 2003
and April 2009 from the ICU in The Burn Center at Uppsala Univer-
sity Hospital, which is one of two national centers responsible for
the in-hospital care of severe burn victims in Sweden, which has
a population of 9.3 million. The Uppsala Burn Center is a referral
center for patients primarily from the northern and middle parts
of Sweden.
Inclusion criteria were (i) age between 18 and 60 years; (ii)
burn injury exceeding 10% TBSA; (iii) admission to the Burn Center
within 48 h after injury; (iv) without ongoing steroid treatment;
and (v) no known neuroendocrine tumor. Before enrollment, infor-
mation about the study was given to the patient or in sedated pa-
tients to a next of kin, by a research nurse who also secured formal
consent for participation.
Fifty-two patients fulﬁlled the inclusion criteria. Only one of
these declined participation, resulting in the inclusion of 51 pa-
tients. Sufﬁcient reliable data for SOFA scoring seven days after in-
jury were, however, only documented in 39 patients. Table 1
shows the study population.
The study was approved by the Uppsala University Ethics Com-
mittee, and the investigation was performed according to the Dec-
laration of Helsinki.2.2. Procedure
Blood samples for analysis of P-CgA were taken twice daily at
6 am and 6 pm.Clinical information required for SOFA-scoring was documented
as part of a structured ICU-routine.
2.3. Measurements
SOFA scores were calculated according to the Swedish Intensive
Care Registry (SIR) guidelines (Swedish-Intensive-Care-Registry,
2010). SOFA scores were created for days 6, 7 and 8 after the injury,
at 6 am. SOFA scores were then time matched to best ﬁt 168 h
(7 days) after the injury, which means that the SOFA score relates
to exactly 7 days ± 12 h after injury.
P-CgA was determined using a commercial radioimmunoassay
(Eurodiagnostica, Malmö, Sweden). The measurements were per-
formed at the certiﬁed Clinical Chemistry Laboratory at the Upp-
sala University Hospital.
2.4. Statistical analysis
Four different variables reﬂecting P-CgA were used for predic-
tions: the 24 h after injury value, as well as the mean and maxi-
mum values during the ﬁrst 7 days, and the concentration vs.
time area under the curve (AUC) based on linear interpolation be-
tween values from days 1 to, and including day 7 after injury. For
P-CgA measurements at 24 h, the closest match with respect to
time was used.
All analyses were deﬁned a priori. The Chi-square test was used
for categorical variables, and the Mann Whitney U-test for ordinal
and continuous variables. Variables signiﬁcantly skewed according
to the Kolmogorov–Smirnov test were logarithmically transformed
to obtain normality when needed. Pearson correlation coefﬁcients
are reported.
Where multiple regressions were made, variables with a p-va-
lue < 0.1 in simple regressions were included in subsequent multi-
ple regressions.
In the prediction analysis of signiﬁcant organ dysfunction SOFA
scores were dichotomized into one group with scores less than 4,
and one with scores of 4 and above, before logistic regression
and ROC-analysis were performed.
All calculations were performed using the IBM SPSS Software
Statistics, version 19.0.0.
3. Results
We ﬁrst assessed the dynamics of P-CgA over time up to and
including day 7 in all patients. There were considerable differences
Fig. 1. Individual P-CgA changes over time clustered into two variability groups. (A) low variability, intraindividual range <6 nmol/L. (B) high variability, intraindividual range
P6 nmol/L. (C and D) coefﬁcient of variation (CV%) and increase in P-CgA from day 1 to day 7 respectively, for both groups. Mean ± SD.
A.E. Lindahl et al. / Neuropeptides 47 (2013) 207–212 209between different patients with respect to the secretion pattern
over time. Two different secretion patterns could, however, be dis-
cerned based on variability between measurements (Fig. 1 A and
B). In one group, constituting about two thirds of the patients,
there was very low variability in P-CgA concentration during the
ﬁrst 7 days after injury. In the remaining third of the patients there
was clearly more variability in P-CgA concentration over time. For
further analyses we delineated these groups by calculating the
greatest difference between two P-CgA values in each patient, i.e.
the intraindividual range, and split the patients into two groups,
with the cutoff at a range of P6 nmol/L. The high variability pa-
tients were shown to have a greater overall increase in P-CgA dur-
ing the ﬁrst 7 days than those with low variability (Fig. 1 C and D;
Table 2). They were also older, had larger full thickness burns and
were subject to more frequent surgery during the ﬁrst 7 days. Also,
there was a tendency for high variability patients to spend more
days with mechanical ventilation during the ﬁrst 7 daysTable 2
Clinical variables in the two patient groups with d
P-CgA range of 6 nmol/L or more was used to de
Low va
Number of patients 34
Age at injury (years) 37.8 ±
Males/Females 25/9
TBSA burned (percent) 27.5 (1
TBSA full thickness burn (percent) 10.3 (0
Days with mechanical ventilation 4.5 (0–
Surgery the ﬁrst 7 days (days) 0.76 ±
Hypothermic episode <36 C (days) 0 (0–3
Increase in P-CgA (nmol/L) 1.55 (
CVa P-CgA day 0–7 0.20 ±
Age and days of surgery are given as mean ± SD
Gender is given as integers.
All other variables are given as median with mi
a CV = coefﬁcient of variation.(p = 0.053). Finally, those patients exhibited poorer multiple organ
function at day 7 (SOFA score 5.6 ± 3.4 vs. 3.0 ± 2.5; p = 0.007).
Total burn size did not correlate with any of the measurements
of P-CgA. The size of the deep burn, however, correlated with the
maximum value for P-CgA (r = 0.30, p = 0.04), but not with the
three remaining measurements. Furthermore, age correlated with
all measurements of P-CgA with r-values of 0.30–0.46 and p-values
of 0.03–0.001.
All four different measures of P-CgA used for predictions corre-
lated with SOFA scores at day 7 (Fig. 2). To analyze the predictive
qualities of the different measurements of P-CgA further, age,
TBSA% burned, and P-CgA were assessed by simple linear regres-
sions (Table 3). Here, age, TBSA% burned and three of the different
measures of CgA were found to be signiﬁcant predictors of SOFA at
day 7, while the fourth, P-CgA AUC 1–7 days, was not.
In subsequent multiple regressions, age and TBSA% burned
signiﬁcantly predicted SOFA at day 7 with an adjusted R2 of 0.27ifferent P-CgA variability. An intraindividual
ﬁne the high variability group.
riability High variability p-Value
17
12.3 46.7 ± 12.1 0.02
11/6 0.52
0.0–55.8) 36.3 (14.5–95.5) 0.11
–52.5) 28.0 (0–94.5) 0.02
8) 7.0 (0–8) 0.05
0.65 1.18 ± 0.64 0.02
) 1 (0–4) 0.13
0.9–5.3) 7.1 (2.8–13.2) <0.001
0.07 0.37 ± 0.10 <0.001
.
nimum and maximum values.
Fig. 2. Scatter plots showing SOFA scores 7 days after injury vs. four different measures of CgA.
Table 3
Univariate regressions with age, TBSA burned, and the different measures of P-CgA as independent variables
and day 7 SOFA scores as the dependent variable.
Covariates Beta p-Value Adjusted R2
Age 0.27 0.10 0.05
TBSA full thickness burna 0.31 0.07 0.07
TBSA burneda 0.42 0.009 0.17
P-CgA at 24 ha 0.45 0.005 0.18
P-CgA maximum value up to day 7a 0.47 0.003 0.20
P-CgA mean value up to day 7a 0.42 0.008 0.16
P-CgA AUC 1–7 daysa 0.33 0.11 0.07
a Logarithmically transformed data.
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addition of the 24 h after injury value, the clinically most practical
measure of P-CgA, thus resulted in a prediction equation with an
adjusted R2 of 0.34. The addition of the mean or maximum P-CgA
value resulted in similar predictions with adjusted R2-values of
0.33 and 0.34, respectively.
In order to better assess the relation between sympathetic
stress measured by P-CgA and clinically relevant multiple organ
dysfunction, the day 7 SOFA value was dichotomized into one
group with high scores and one group with low scores in a way
that as nearly as possible split the study population in half. By
deﬁning low SOFA as less than 4 and high SOFA as 4 or more,
56% of the patients were in the low SOFA group and the rest in
the high SOFA group. Receiver operator curves showed that TBSA%
burned and age weakly predicted having a high SOFA with AUCs of
0.61 and 0.72, respectively. Each of the four CgA-related variables
was a better predictor, with AUCs varying between 0.75 and0.80. While TBSA% and age together gave an AUC of 0.81, the best
prediction was achieved with those two in addition to CgA at 24 h
with an AUC of 0.90 (Fig. 3).4. Discussion
The results clearly show that not only the extent of the burn in-
jury, but also characteristics of the individual’s sympathetic re-
sponse to injury deﬁne the risk for organ dysfunction during the
acute intensive care. Thus the data support the hypothesis that sin-
gle high P-CgA values predict organ dysfunction, measured as SOFA
score, one week after a major burn injury demanding intensive
care. These data are convincing, since not only a point measure
at 24 h, but also the mean, maximum and integrated values of P-
CgA during the ﬁrst 7 days correlated with the SOFA score at day
7. The data also support P-CgA as a stronger predictor of organ
Table 4
Multiple regressions with age, TBSA burned, and different measures of P-CgA as
independent variables and SOFA scores at day 7 as the dependent variable.
Covariates Beta p-Value Adjusted R2 p-Value
Age 0.38 0.01
TBSA burneda 0.50 0.001
0.27 0.001
Age 0.25 0.09
TBSA burneda 0.43 0.004
P-CgA at 24 ha 0.44 0.004
0.34 0.001
Age 0.23 0.14
TBSA burneda 0.47 0.002
P-CgA mean value to day 7a 0.35 0.026
0.34 0.001
Age 0.22 0.17
TBSA burneda 0.41 0.006
P-CgA maximum value to day 7a 0.34 0.03
0.33 0.001
Age
TBSA burneda
P-CgA AUC 1–7 daysa 0.26 0.18 ns
a Logarithmically transformed data, ns = not signiﬁcant.
Fig. 3. Receiver operator curves (ROC) for logistic regression analyses with
dichotomized SOFA score as dependent variable.
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dictors of organ dysfunction. Furthermore, patients with higher
variability in their P-CgA values were older, had larger deep burns,
more frequent surgery and higher SOFA scores than the other
patients.
The SOFA score was originally designed to quantitatively de-
scribe organ dysfunction over time and to evaluate Vincent et al.,
1998). It was later understood that the score could also be applied
in non-septic patients (Vincent et al., 2000). The SOFA score is the
sum of subscores for six organ systems: respiratory, circulatory, re-
nal, hematologic, hepatic and central nervous systems, depending
on the level of dysfunction (rated as 1–4 points) for each. The SOFA
score has also been used to predict mortality, although it was not
originally developed for this function. The prognostic performance
of the SOFA score when used in various models for predicting mor-
tality in adult patients in medical and/or surgical ICUs was recently
systematically reviewed (Minne et al., 2008). SOFA scores onadmission, or various models of combinations of sequential SOFA
scores, were conﬁrmed to predict mortality in patients in general
medical and/or surgical ICUs.
About one third of the patients exhibited a large variability in P-
CgA between different sampling times. Although few studies have
been conducted on the intra-individual variability in P-CgA, the
variability in the present study is larger than previously reported
in healthy individuals or in individuals not treated in ICUs. In the
latter, the intra-individual coefﬁcient of variation was found to
be 0.13 in healthy individuals when assessed at four monthly inter-
vals (Dittadi et al., 2004), and 0.29 ± 0.07 when determined repeat-
edly over 24 h (Takiyyuddin et al., 1991). In the present study the
high variability patients had a considerably higher coefﬁcient of
variation (0.37 ± 0.10), while the low variability patients had a
coefﬁcient of variation within the range found in healthy individu-
als (0.20 ± 0.07). This must be considered in the context of the ex-
pected coefﬁcient of variation for the analysis as such, which is
close to 0.09 when used in clinical routine (data from the Clinical
Chemistry Laboratory), and taking into account observations that
even under intense to extreme acute sympathoadrenal stimula-
tion, CgA levels do not increase more than two fold (Cryer et al.,
1991; Elias et al., 1992). The larger variability must therefore be
interpreted as a more intense and protracted sympathoadrenal
stimulation in high than in low variability patients.
We also considered the possibility that intoxication with carbon
monoxide would have affected the CgA levels. However, the num-
ber of patients with carbon monoxide concentration in the present
patient sample was low, only four out of the 50 patients (Table 1),
and data analysis excluding those four patients did not change the
results of the study (data not shown).
A limitation of this study is that it is a single center study with a
relatively small number of included patients, which restricted full
exploitation of desired statistical strategies. For example, it was
necessary to dichotomize the SOFA scores in logistic regressions
by splitting the population nearly in half, which was at a SOFA
score of 4. This cutoff was arbitrary, without any known corre-
sponding dichotomy in outcome, although it is known that organ
dysfunction after one week in the ICU constitutes a great risk for
the patient (Van den Berghe, 2000).
Another limitation is that starting on admission all patients
were routinely treated orally with the proton pump inhibitor ome-
prazol, which is known to increase the plasma concentration of
CgA in the subgroup of individuals who have a mutated CYP2C19
(Sagar et al., 2000; Pregun et al., 2011). This effect is mediated by
the hypergastrinemia that may follow such treatment (Sanduleanu
et al., 1999). On the other hand, such an effect cannot explain the
predictive value of P-CgA at 24 h. Also, some patients were treated
with metoprolol as part of the ICU routine. However, it has been
observed that this does not affect the P-CgA concentration (Tak-
iyyuddin et al., 1991).
A third limitation is that the sympathetic response was not val-
idated by measurements of plasma catchecholamine concentra-
tions. However, when designing this study we decided not to
assess catecholamine concentrations in vivo for several reasons.
One is the very short half-life of catecholamines in the circulation
(a few minutes), which would make point measures difﬁcult to
interpret. Another pragmatic reason, actually the predominant rea-
son, is that exogenous catecholamines are administered to many
patients during different periods as part of their critical care. In ret-
rospect, we regret not having measured catecholamines, as the re-
sults could possibly have been of value.
On the other hand, the strengths of this study are the prospec-
tive design, the consecutive recruitment of patients to the study,
and the fact that the Uppsala Burn Center is one of the two existing
national referral units, which makes the sample quite representa-
tive of Swedish adult patients with burns.
212 A.E. Lindahl et al. / Neuropeptides 47 (2013) 207–212The results motivate a more extensive effort to evaluate P-CgA
as an independent prognostic marker also with respect to mortal-
ity and long-term outcome, and to further assess the putative role
of the CgA related split products in the complex pathophysiology of
the circulatory system after large burns.Conﬂict of interest
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or ethical conﬂicts of interest regarding the contents of the
submission.
Acknowledgements
We are indebted to Ms Emily Gaufﬁn for excellent database
work, to Dr Lars Berglund, PhD, for statistical review, and to Ms
Jane Wigertz for language revision.
References
ABA, 2011. ‘‘American Burn Association National Burn Repository 2011 Annual
Report.’’ Available from: <http://www.ameriburn.org/2011NBRAnnualReport.
pdf>.
Cryer, P.E., Wortsman, J., Shah, S.D., Nowak, R.M., Deftos, L.J., 1991. Plasma
chromogranin A as a marker of sympathochromafﬁn activity in humans. Am.
J. Physiol. 260 (2 Pt 1), E243–E246.
Dittadi, R., Meo, S., Gion, M., 2004. Biological variation of plasma chromogranin A.
Clin. Chem. Lab. Med. 42 (1), 109–110.
Dunser, M.W., Hasibeder, W.R., 2009. Sympathetic overstimulation during critical
illness: Adverse effects of adrenergic stress. J. Intensive Care Med. 24 (5), 293–
316.
Elias, A.N., Wilson, A.F., Pandian, M.R., Kayaleh, R., 1992. Chromogranin A
concentrations in plasma of physically active men after acute exercise. Clin.
Chem. 38 (11), 2348–2349.
Galeiras, R., Lorente, J.A., Pertega, S., Vallejo, A., Tomicic, V., de la Cal, M.A., et al.,
2009. A model for predicting mortality among critically ill burn victims. Burns
35 (2), 201–209.
Lionelli, G.T., Pickus, E.J., Beckum, O.K., Decoursey, R.L., Korentager, R.A., 2005. A
three decade analysis of factors affecting burn mortality in the elderly. Burns 31
(8), 958–963.
Lorente, J.A., Vallejo, A., Galeiras, R., Tomicic, V., Zamora, J., Cerda, E., et al., 2009.
Organ dysfunction as estimated by the sequential organ failure assessment
score is related to outcome in critically ill burn patients. Shock 31 (2), 125–131.
Mazza, R., Imbrogno, S., Tota, B., 2010. The interplay between chromogranin A-
derived peptides and cardiac natriuretic peptides in cardioprotection against
catecholamine-evoked stress. Regul. Pept. 165 (1), 86–94.Minne, L., Abu-Hanna, A., de Jonge, E., 2008. Evaluation of SOFA-based models for
predicting mortality in the ICU: A systematic review. Crit. Care 12 (6), R161.
Morita, S., Higami, S., Yamagiwa, T., Iizuka, S., Nakagawa, Y., Yamamoto, I., et al.,
2010. Characteristics of elderly Japanese patients with severe burns. Burns 36
(7), 1116–1121.
Nakae, H., Wada, H., 2002. Characteristics of burn patients transported by
ambulance to treatment facilities in Akita Prefecture, Japan. Burns 28 (1), 73–
79.
Nguyen, L.N., Nguyen, T.G., 2009. Characteristics and outcomes of multiple organ
dysfunction syndrome among severe-burn patients. Burns 35 (7), 937–941.
Pregun, I., Herszenyi, L., Juhasz, M., Miheller, P., Hritz, I., Patocs, A., et al., 2011. Effect
of Proton-pump inhibitor therapy on serum chromogranin A level. Digestion 84
(1), 22–28.
Røsjø, H., Masson, S., Latini, R., Flyvbjerg, A., Milani, V., La Rovere, M.T., et al., 2010.
Prognostic value of chromogranin A in chronic heart failure: Data from the
GISSI-Heart Failure trial. Eur. J. Heart Fail. 12 (6), 549–556.
Sagar, M., Bertilsson, L., Stridsberg, M., Kjellin, A., Mardh, S., Seensalu, R., 2000.
Omeprazole and CYP2C19 polymorphism: Effects of long-term treatment on
gastrin, pepsinogen I, and chromogranin A in patients with acid related
disorders. Aliment. Pharmacol. Ther. 14 (11), 1495–1502.
Sanduleanu, S., Stridsberg, M., Jonkers, D., Hameeteman, W., Biemond, I., Lundqvist,
G., et al., 1999. Serum gastrin and chromogranin A during medium- and long-
term acid suppressive therapy: A case-control study. Aliment. Pharmacol. Ther.
13 (2), 145–153.
Smith, D.L., Cairns, B.A., Ramadan, F., Dalston, J.S., Fakhry, S.M., Rutledge, R., et al.,
1994. Effect of inhalation injury, burn size, and age on mortality: A study of
1447 consecutive burn patients. J. Trauma 37 (4), 655–659.
Swedish-Intensive-Care-Registry, 2010. ‘‘SOFA regstration.’’ Available from: <http://
www.icuregswe.org/sv/Riktlinjer/SOFA-registrering/>.
Takiyyuddin, M.A., Baron, A.D., Cervenka, J.H., Barbosa, J.A., Neumann, H.P., Parmer,
R.J., et al., 1991. Suppression of chromogranin-A release from neuroendocrine
sources in man: Pharmacological studies. J. Clin. Endocrinol. Metab. 72 (3), 616–
622.
Tanaka, Y., Shimizu, M., Hirabayashi, H., 2007. Acute physiology, age, and chronic
health evaluation (APACHE) III score is an alternative efﬁcient predictor of
mortality in burn patients. Burns 33 (3), 316–320.
Taupenot, L., Harper, K.L., O’Connor, D.T., 2003. The chromogranin–secretogranin
family. N. Engl. J. Med. 348 (12), 1134–1149.
Van den Berghe, G., 2000. Novel insights into the neuroendocrinology of critical
illness. Eur. J. Endocrinol. 143 (1), 1–13.
Vincent, J.L., de Mendonca, A., Cantraine, F., Moreno, R., Takala, J., Suter, P.M., et al.,
1998. Use of the SOFA score to assess the incidence of organ dysfunction/failure
in intensive care units: results of a multicenter, prospective study. Working
group on ‘‘sepsis-related problems’’ of the European Society of Intensive Care
Medicine. Crit. Care Med. 26 (11), 1793–1800.
Vincent, J.L., Ferreira, F., Moreno, R., 2000. Scoring systems for assessing organ
dysfunction and survival. Crit. Care Clin. 16 (2), 353–366.
Zhang, D., Lavaux, T., Sapin, R., Lavigne, T., Castelain, V., Aunis, D., et al., 2009. Serum
concentration of chromogranin A at admission: An early biomarker of severity
in critically ill patients. Ann. Med. 41 (1), 38–44.
Zhang, D., Lavaux, T., Voegeli, A.C., Lavigne, T., Castelain, V., Meyer, N., et al., 2008.
Prognostic value of chromogranin A at admission in critically ill patients: A
cohort study in a medical intensive care unit. Clin. Chem. 54 (9), 1497–1503.
